• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 106015
Device Problems Infusion or Flow Problem (2964); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Anemia (1706); Fatigue (1849); Dizziness (2194); Gastrointestinal Hemorrhage (4476); Melena (4480)
Event Date 12/25/2023
Event Type  Injury  
Event Description
It was reported that the patient was experiencing low flow alarms, and their stools were dark for a few days.The patient also reported dizziness.The ventricular assist device (vad) parameters included the speed being at 8600 rotations per minute (rpm), backup speed at rpm 8200, power of 4.3 watts, estimated flow of 3.5 liters per minute, pulsatility index (pi) of 6.5, and a mean arterial pressure (map) of 86.The patient was routed to the emergency department.Low voltage advisory and 17 low flow alarms were reported on vad interrogation.It was noted that the patient had a history of symptomatic anemia secondary to gastrointestinal bleed and was on the medication octreotide as an outpatient.Log files were sent for review.The log file captured several low flow events.The plan was for admission and esophagogastroduodenoscopy (egd).
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is complete.
 
Event Description
It was reported that the patient was experiencing low flow alarms due to low hemoglobin.The patient also reported fatigue.It was noted that the patient had a history of symptomatic anemia secondary to gastrointestinal bleed, starting on (b)(6) 2023, and was on the medication octreotide as an outpatient.Log files were sent for review.It was later reported that the low flow alarms resolved by repleting blood by a transfusion.The bleeding was confirmed, and the sources were multiple angiodysplasia in the duodenum and jejunum.The bleeding was treated with ablation with 1 active bleeding angiodysplasia remaining in the jejunum.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct correlation between heartmate ii left ventricular assist system (lvas), serial number (b)(6) and the reported gastrointestinal bleeding, could not be conclusively established.Additionally, the report of low flow alarms was confirmed via the submitted log files.According to the account, the low flows were due to low hemoglobin.Analysis of the submitted log file revealed low flow events on 25dec2023 and 26dec2023 when the flow decreased below the 2.5 liters per minute (lpm) alarm threshold.The pump appeared to function as intended and operated at the fixed speed without issue for the duration of the file.The patient remains ongoing on heartmate ii lvas, serial number (b)(6) with no further issues reported at this time.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate ii lvas instructions for use (ifu), rev.C, and the heartmate ii lvas patient handbook, rev.C, are currently available.Section 1 of this ifu lists bleeding as an adverse event that may be associated with the use of the hm ii lvas.This document also provides information regarding the recommended anticoagulation therapy and international normalized ratio (inr) range, as well as the suggested anticoagulation modifications in the event that there is a risk of bleeding.Pump speed, power, flow, and pi are also addressed in section 1.The ifu notes that the low flow alarm is triggered when the flow is less than 2.5 lpm.Section 7 of the ifu, ¿alarms and troubleshooting¿, and section 5 of the patient handbook, ¿alarms and troubleshooting¿, describe alarm conditions, including the low flow hazard, as well as the appropriate actions associated with them.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS)
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
lindsey sallese
6035 stoneridge drive
pleasanton, CA 94588
7818528207
MDR Report Key18448025
MDR Text Key332154899
Report Number2916596-2024-00055
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024011224
UDI-Public00813024011224
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 03/07/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/04/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/31/2017
Device Model Number106015
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/04/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/25/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age78 YR
Patient SexFemale
Patient Weight87 KG
-
-